LIFYORLI (COPACKAGED) vs ZEJULA

Independent side-by-side comparison.

Rated against independent regulatory sources·Last updated August 11, 2026·How we rate

Possible drug interaction. LIFYORLI (COPACKAGED) and ZEJULA are different prescription medicines. Combining or switching between them can cause interactions — talk to a pharmacist or prescriber before making changes. This page is not medical advice.

Attribute	LIFYORLI (COPACKAGED)	ZEJULA
Rating	New	70/100
Pharmacy pays	—	—
Type	RX	RX
Active ingredient	RELACORILANT	NIRAPARIB TOSYLATE
Manufacturer	Corcept Therap	Glaxosmithkline
Dosage forms	Kit	Tablet
Drug class	—	—
Boxed warning	None	None
Treats	Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, Peritoneal Neoplasms	Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

lifyorli (copackaged)zejula

Rating

New

70/100

Pharmacy pays

—

Type

Active ingredient

RELACORILANT

NIRAPARIB TOSYLATE

Manufacturer

Corcept Therap

Glaxosmithkline

Dosage forms

Kit

Tablet

Drug class

—

Boxed warning

None

Treats

Ovarian Epithelial Carcinoma, Fallopian Tube Neoplasms, Peritoneal Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms, Peritoneal Neoplasms

Frequently asked questions

What is the difference between Lifyorli (Copackaged) and Zejula?

Lifyorli (Copackaged) contains Relacorilant, while Zejula contains Niraparib Tosylate — they have different active ingredients.

Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.